United States — ClinicalTrials.gov
Tracked across 3 events · 18 articles · First seen May 26, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
A study published in PLOS on August 19, 2026, analyzed all 1,357 AI-based medical devices authorized by the U.S. United States — Food and Drug Administration (FDA) as of December 5, 2025. The researchers, led…
Impact: The registry was used to identify trials; the study highlights the low number of registered trials for AI devices.
Aug 19, 2026 · 6 articles
Business
Impact: United States — ClinicalTrials.gov is a source of information for the AimwellBio Observer network, providing source-traced signals.
Jun 29, 2026 · 6 articles
Tech
Impact: The study was registered on United States — ClinicalTrials.gov>>>, ensuring transparency and adherence to research standards.
May 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United States — ClinicalTrials.gov live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard